Dianthus Therapeutics, Inc.
(NASDAQ: DNTH)
Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company. It designs and delivers novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company was founded on June 17, 2015 and is headquartered in New York, NY.
44.309
-0.396
(-0.89%)
Range
44.085 - 45.075
(2.25%)
Open
44.960
Previous Close
44.705
Bid Price
-
Bid Volume
-
Ask Price
-
Ask Volume
-
Volume
45,439
Value
-
Remark
Delayed prices. Updated at 05 Dec 2025 23:07.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
